Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 17/20 | 0.61 |
| ▸ | BTK | Q06187 | 14/20 | 0.61 |
| ▸ | LCK | P06239 | 16/20 | 0.60 |
| ▸ | EGFR | P00533 | 11/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21946711 | 0.90 | JAK3 (0.72) | JAK3BTKLCKEGFR | |
| SCHEMBL26970118 | 0.90 | JAK3 (0.71) | JAK3BTKLCKEGFR | |
| SCHEMBL29546793 | 0.90 | JAK3 (0.71) | JAK3BTKLCKEGFR | |
| SCHEMBL18884597 | 0.90 | JAK3 (0.71) | JAK3BTKLCKEGFR | |
| SCHEMBL21946364 | 0.89 | JAK3 (0.73) | JAK3BTKLCKEGFR | |
| SCHEMBL31039881 | 0.89 | JAK3 (0.73) | JAK3BTKLCKEGFR | |
| Hydrochloric Acid SCHEMBL25198852 | 0.88 | JAK3 (0.72) | JAK3BTKLCKEGFR | |
| SCHEMBL21947880 | 0.87 | BTK (0.57) | JAK3BTKLCKEGFR | |
| SCHEMBL25606965 | 0.87 | JAK3 (0.67) | JAK3BTKLCKEGFR | |
| SCHEMBL18884583 | 0.86 | JAK3 (0.66) | JAK3BTKLCKEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020081450-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY | NURIX THERAPEUTICS, INC. (US) | 2020-04-23 | — | — | WO | disclosed |